As shown by immunoblotting analysis, HER2 is overexpressed in breast cancer AU565 cells but not in aggressive triple negative breast cancer MDA-MB-231 cells or in non-cancerous mammary epithelial MCF10A cells (Supplementary Figure S2A). Here, ERBB2 is linked to breast carcinoma.